Kyobo 8 Special Purpose Acquisition Company (307280) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.063x

Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has a cash flow conversion efficiency ratio of 0.063x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.66 Billion ≈ $1.80 Million USD) by net assets (₩41.96 Billion ≈ $28.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 307280 net asset quality index to measure how much of total assets are equity-financed.

Kyobo 8 Special Purpose Acquisition Company - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Kyobo 8 Special Purpose Acquisition Comp (307280) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Kyobo 8 Special Purpose Acquisition Company Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Econframe Bhd
KLSE:0227
0.041x
Perdana Gapura Prima Tbk
JK:GPRA
-0.009x
Eupe Corporation Bhd
KLSE:6815
0.111x
Renta Corporacion Real Estate SA
MC:REN
0.248x
A2Z Infra Engineering Limited
NSE:A2ZINFRA
-0.172x
Reservoir Link Energy Bhd
KLSE:0219
0.075x
Environmental Group Ltd (the)
AU:EGL
-0.067x
THE INX DIGITAL CO.INC.
F:FN4
N/A

Annual Cash Flow Conversion Efficiency for Kyobo 8 Special Purpose Acquisition Company (2022–2025)

The table below shows the annual cash flow conversion efficiency of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see Kyobo 8 Special Purpose Acquisition Comp (307280) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩42.62 Billion
≈ $28.89 Million
₩8.48 Billion
≈ $5.75 Million
0.199x -16.18%
2024-12-31 ₩37.27 Billion
≈ $25.26 Million
₩8.85 Billion
≈ $6.00 Million
0.237x +60.22%
2023-12-31 ₩32.62 Billion
≈ $22.11 Million
₩4.84 Billion
≈ $3.28 Million
0.148x -31.24%
2022-12-31 ₩26.83 Billion
≈ $18.18 Million
₩5.78 Billion
≈ $3.92 Million
0.216x --

About Kyobo 8 Special Purpose Acquisition Company

KQ:307280 Korea Medical Instruments & Supplies
Market Cap
$25.05 Million
₩36.96 Billion KRW
Market Cap Rank
#24368 Global
#1715 in Korea
Share Price
₩5420.00
Change (1 day)
-3.56%
52-Week Range
₩5290.00 - ₩5620.00
All Time High
₩5620.00
About

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more